Genomma Lab Internacional, S.A.B. de C.V.
GNMLF
$0.96
$0.010.82%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 23.31M | 18.20M | 24.42M | 21.29M | 34.92M |
| Total Depreciation and Amortization | 5.12M | 4.72M | 4.75M | 6.04M | 4.68M |
| Total Amortization of Deferred Charges | -- | -- | -- | 596.60K | -- |
| Total Other Non-Cash Items | 2.89M | 14.74M | 7.36M | -1.67M | 8.26M |
| Change in Net Operating Assets | -7.67M | -11.53M | -43.93M | 37.75M | 29.56M |
| Cash from Operations | 23.65M | 26.13M | -7.40M | 64.00M | 77.42M |
| Capital Expenditure | -7.02M | -4.44M | -5.19M | -8.35M | -2.18M |
| Sale of Property, Plant, and Equipment | 6.40K | 151.00K | -- | 462.00K | 104.90K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.28M | -1.02M | 1.74M | 6.36M | -27.99M |
| Cash from Investing | -9.29M | -5.30M | -3.45M | -1.53M | -30.06M |
| Total Debt Issued | 1.15B | 2.40B | 850.00M | 727.22M | 1.26B |
| Total Debt Repaid | -999.49M | -2.10B | -351.35M | -913.66M | -1.15B |
| Issuance of Common Stock | -- | 36.08M | -- | 1.64B | -- |
| Repurchase of Common Stock | -28.76M | -- | -55.93M | -1.66B | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -21.00M | 0.00 | -9.57M | -9.12M | -10.35M |
| Other Financing Activities | -186.45M | -191.58M | -214.83M | -228.95M | -227.43M |
| Cash from Financing | -24.51M | 7.21M | 1.59M | -30.84M | -16.57M |
| Foreign Exchange rate Adjustments | -3.31M | -6.05M | -697.60K | 1.19M | 2.17M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.45M | 21.99M | -9.95M | 32.82M | 32.95M |